Psychiatry and Clinical Neurosciences · 2016 · 18 citations · 16 references
MedicinePharmacologyPsychiatryAdult PsychiatryClinical PharmacologyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDepression PharmacotherapyDepressive DisordersDextrose AdministrationComorbid Mental Health DisordersDepressive Symptom AssessmentFunctional Impairment SeverityIntravenous Infusion SolutionsMagnesium ConcentrationPlacebo ComparatorsSerum Magnesium Measurement
AIM: Treatment-resistant depression patients are more likely to suffer from comorbid physical and mental disorders, experience marked and protracted functional impairment, and incur higher health-care costs than non-affected individuals. Magnesium sulfate is a treatment option that may offer great potential for patients with treatment-resistant depression based on prior work in animals and humans. METHODS: Twelve subjects with mild or moderate treatment-resistant depression were randomized into a double-blind crossover trial to receive an infusion of 4 g of magnesium sulfate in 5% dextrose or placebo infusion of 5% dextrose with a 5-day washout in between the 8-day intervention period. Subjects were assessed before and after the intervention for serum and urine magnesium, lipid panel, the Hamilton Rating Scale for Depression, and the Patient Health Questionnaire-9. RESULTS: We found a difference in serum magnesium from day 2 to 8 (pre-infusion) (P < 0.002) and from baseline to day 8 (P < 0.02). No changes were noted on the Hamilton Rating Scale for Depression or the Patient Health Questionnaire-9 24 h post-treatment, but as serum magnesium increased from baseline to day 7, the Patient Health Questionnaire-9 decreased from baseline to day 7 (P = 0.02). CONCLUSION: Magnesium sulfate did not significantly affect depression 24 h post-infusion, but other results were consistent with the literature. The association between changes in serum magnesium and the Patient Health Questionnaire-9 supports the idea that magnesium sulfate may be used to address treatment-resistant depression, an ongoing medical challenge.
16
Kurt Kroenke, Robert L. Spitzer, Janet B. W. Williams · Journal of General Internal Medicine · 2001 · 44.2K citations · Full text
M. Hamilton · Journal of Neurology Neurosurgery & Psychiatry · 1960 · 32.6K citations · Full text
THE ASSESSMENT OF ANXIETY STATES BY RATING
Max Hamilton · British Journal of Medical Psychology · 1959 · 11.4K citations
Max Hamilton · PubMed · 1980 · 471 citations